tag:www.gov.uk,2005:/government/organisations/advisory-council-on-the-misuse-of-drugs Advisory Council on the Misuse of Drugs - Activity on 바카라 사이트 HM 바카라 사이트 2025-05-28T13:41:33Z /government/publications/a-whole-system-response-to-drug-prevention-in-the-uk#2025-05-28T13:41:33Z 2025-05-28T13:41:33Z Independent report: A whole-system response to drug prevention in the UK Report on the long-term prevention of drug use and related harms among young people. /government/publications/semi-synthetic-cannabinoids-related-to-tetrahydro-cannabinol-and-cannabidiol#2025-05-23T10:52:00Z 2025-05-23T10:52:00Z Independent report: Semi-synthetic cannabinoids related to tetrahydro-cannabinol and cannabidiol ACMD review into the use and harms of SSCs and THCA to identify compounds causing harm which are not captured by the current generic definition for cannabinoids. /government/publications/advisory-council-on-the-misuse-of-drugs-member-biographies#2025-05-20T12:45:22Z 2025-05-20T12:45:22Z Transparency data: Advisory Council on the Misuse of Drugs member biographies Biographies of members of the Advisory Council on the Misuse of Drugs. /government/publications/acmd-work-programme-2025#2025-03-12T12:00:02Z 2025-03-12T12:00:02Z Correspondence: ACMD work programme 2025 Letter to the Home Secretary from the Chair of the Advisory Council on the Misuse of Drugs (ACMD) discussing the ACMD work programme for 2025. /government/publications/synthetic-cathinones-an-updated-harms-assessment#2025-02-12T17:13:30Z 2025-02-12T17:13:30Z Research: Synthetic cathinones: an updated harms assessment ACMD has written an updated harms assessment describing the use and harms of synthetic cathinones following a government commission. /government/news/acmd-appoints-new-members#2025-02-10T12:52:27Z 2025-02-10T12:52:27Z ACMD appoints new members Four more experts have been appointed members to the Advisory Council on the Misuse of Drugs. /government/publications/members-register-of-interests#2025-02-10T12:45:17Z 2025-02-10T12:45:17Z Corporate report: ACMD members' register of interests Occupations, career history and interests of the members of the Advisory Council on the Misuse of Drugs (ACMD). /government/publications/acmd-advice-on-2-benzyl-benzimidazole-and-piperidine-benzimidazolone-opioids#2025-01-29T16:04:55Z 2025-01-29T16:04:55Z Research: ACMD advice on 2-benzyl benzimidazole and piperidine benzimidazolone opioids A review of the evidence on the use and harms of 2-benzyl benzimidazole (nitazene) and piperidine benzimidazolone (brorphine-like) opioids. /government/publications/updated-harms-assessment-of-ketamine-commissioning-letter#2025-01-16T07:58:29Z 2025-01-16T07:58:29Z Correspondence: Updated harms assessment of ketamine: commissioning letter The government commissions the Advisory Council on the Misuse of Drugs (ACMD) to conduct an updated harms assessment of ketamine. /government/news/acmd-appoints-10-leading-experts#2025-01-13T00:00:00Z 2025-01-13T00:00:00Z ACMD appoints 10 leading experts Ten leading experts have joined the Advisory Council on the Misuse of Drugs (ACMD) to strengthen its vital work advising the government on drug harms. /government/publications/standard-operating-procedure-for-using-evidence-in-acmd-reports#2025-01-03T12:00:02Z 2025-01-03T12:00:02Z Corporate report: Standard Operating Procedure for using evidence in ACMD reports A document developed by the Advisory Council on the Misuse of Drugs (ACMD) to outline the governing process for preparing evidence-based advice. /government/publications/acmd-annual-report-2020-to-2022#2024-12-20T12:00:00Z 2024-12-20T12:00:00Z Corporate report: ACMD annual report 2020 to 2022 Overview of the Advisory Council on the Misuse of Drugs' (ACMD) work from January 2020 to December 2022. /government/publications/acmd-advice-on-reform-to-hemp-licensing-fees#2024-10-23T13:53:47Z 2024-10-23T13:53:47Z Correspondence: ACMD advice on reform to hemp licensing fees The Advisory Council on the Misuse of Drugs responds to the government on their proposal to amend the licensing regimen for industrial hemp. /government/publications/alkyl-nitrites-acmd-exemption-consideration#2024-08-09T12:34:19Z 2024-08-09T12:34:19Z Research: Alkyl nitrites: ACMD exemption consideration The Advisory Council on the Misuse of Drugs has provided an updated harms assessment of alkyl nitrites. /government/calls-for-evidence/synthetic-cathinones#2024-05-20T11:00:00Z 2024-05-20T11:00:00Z Synthetic cathinones The Novel Psychoactive Substances Committee (NPSC) is seeking evidence for its review of the evidence of the misuse and harms of synthetic cathinones in the UK. /government/publications/government-response-to-the-acmds-report-on-novel-benzodiazepines#2024-05-14T11:00:02Z 2024-05-14T11:00:02Z Correspondence: 바카라 사이트 response to the ACMD's report on novel benzodiazepines The government responds to the ACMD's report on recently encountered novel benzodiazepines and related compounds. /government/publications/government-response-to-acmd-report-on-acyl-piperazine-opioids#2024-05-14T11:00:02Z 2024-05-14T11:00:02Z Correspondence: 바카라 사이트 response to ACMD report on acyl piperazine opioids 바카라 사이트 response to the report by the Advisory Council on the Misuse of Drugs on acyl piperazine opioids, including 2-methyl-AP-237. /government/publications/reform-to-the-fees-applicable-under-the-hemp-licensing-regime#2024-04-09T11:00:08Z 2024-04-09T11:00:08Z Correspondence: Reform to the fees applicable under the hemp licensing regime The government commissions the Advisory Council on the Misuse of Drugs (ACMD) to review the fees applicable under the hemp licensing regime. /government/publications/acmd-work-programme-2024#2024-04-05T11:00:13Z 2024-04-05T11:00:13Z Correspondence: ACMD work programme 2024 ACMD work programme 2024 letter to the Home Secretary from the Chair of the Advisory Council on the Misuse of Drugs (ACMD). /government/publications/uncontrolled-novel-benzodiazepines-2024-update#2024-03-28T00:00:00Z 2024-03-28T00:00:00Z Research: Uncontrolled novel benzodiazepines: 2024 update A review of the evidence on the use, harms and prevalence of recently encountered uncontrolled novel benzodiazepines and related compounds (2024 update).